{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:30:52Z","timestamp":1787031052149,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.4158\/ep14483.or","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T21:15:35Z","timestamp":1426713335000},"page":"743-749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment With Cinacalcet Increases Plasma Adiponectin Concentration in Hemodialyzed Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism"],"prefix":"10.1016","volume":"21","author":[{"given":"Piotr","family":"Kuczera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Adamczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Machnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogus\u0144aw","family":"Okopie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wiecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP14483.OR_bb0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pharmthera.2005.06.019","article-title":"Pharmacological and clinical properties of calcimimetics, calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism","volume":"109","author":"Nagano","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.4158\/EP14483.OR_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0272-6386(99)70106-X","article-title":"Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients","volume":"34","author":"Navarro","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.4158\/EP14483.OR_bb0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis, a randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.4158\/EP14483.OR_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5414\/CNP74198","article-title":"\u201cReal-World\u201d use of cinacalcet for managing SHPT in different European countries, analysis of data from the ECHO observational study","volume":"74","author":"Vervloet","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.4158\/EP14483.OR_bb0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study, a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.4158\/EP14483.OR_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000347145","article-title":"Cinacalcet improves endothelial dysfunction and cardiac hypertrophy in patients on hemodialysis with secondary hyperparathyroidism","volume":"122","author":"Choi","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.4158\/EP14483.OR_bb0040","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"EVOLVE Trial Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"10.4158\/EP14483.OR_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000313035","article-title":"Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism","volume":"115","author":"Ichii","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.4158\/EP14483.OR_bb0050","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.4158\/EP14483.OR_bb0055","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/ndt\/gfm156","article-title":"Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy","volume":"22","author":"Lomonte","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.4158\/EP14483.OR_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1744-9987.2009.00772.x","article-title":"Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?","volume":"13","author":"Kakuta","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.4158\/EP14483.OR_bb0065","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.2174\/092986707782794096","article-title":"Calcium sensing receptor activators, calcimimetics","volume":"14","author":"Harrington","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.4158\/EP14483.OR_bb0070","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1210\/en.2004-1281","article-title":"Calcium-sensing receptor expression in human adipocytes","volume":"146","author":"Cifuentes","year":"2005","journal-title":"Endocrinology"},{"key":"10.4158\/EP14483.OR_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.abb.2010.05.033","article-title":"Obesity-associated proinflammatory cytokines increase calcium sensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line","volume":"500","author":"Cifuentes","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"10.4158\/EP14483.OR_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11010-008-9872-8","article-title":"Antilipolytic effect of calciumsensing receptor in human adipocytes","volume":"319","author":"Cifuentes","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"10.4158\/EP14483.OR_bb0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbrc.2010.11.129","article-title":"Involvement of calcium-sensing receptor in inhibition of lipolysis through intracellular cAMP and calcium pathways in human adipocytes","volume":"404","author":"He","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.4158\/EP14483.OR_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11010-011-1118-5","article-title":"The calcium-sensing receptor promotes adipocyte differentiation and adipogenesis through PPARg pathway","volume":"361","author":"He","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.4158\/EP14483.OR_bb0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mce.2012.03.006","article-title":"Calcium sensing receptor activation elevates proinflammatory factor expression in human adipose cells and adipose tissue","volume":"361","author":"Cifuentes","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.4158\/EP14483.OR_bb0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/hr.2010.282","article-title":"Potential impact of renin-angiotensin system inhibitors and calcium channel blockers on plasma high-molecular-weight adiponectin levels in hemodialysis patients","volume":"34","author":"Nakagawa","year":"2011","journal-title":"Hypertens Res"},{"key":"10.4158\/EP14483.OR_bb0105","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/ndt\/gfl814","article-title":"Adiponectin-an adipokine with unique metabolic properties","volume":"4","author":"Wiecek","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.4158\/EP14483.OR_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semnephrol.2012.12.008","article-title":"The adipose tissue as an endocrine organ","volume":"33","author":"Adamczak","year":"2013","journal-title":"Semin Nephrol"},{"issue":"Suppl 4","key":"10.4158\/EP14483.OR_bb0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/ndt\/gft365","article-title":"Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients","volume":"28","author":"Spoto","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.4158\/EP14483.OR_bb0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.20452\/pamw.1188","article-title":"Effect of secondary hyperparathyroidism treatment with cinacalcet on selected adipokines and markers of endothelial injury in hemodialysis patients, a preliminary report","volume":"122","author":"Hryszko","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"10.4158\/EP14483.OR_bb0125","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12576-011-0174-7","article-title":"Effects of alfacalcidol on circulating cytokines and growth factors in rat skeletal muscle","volume":"61","author":"Testerink","year":"2001","journal-title":"J Physiol Sci"},{"key":"10.4158\/EP14483.OR_bb0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"key":"10.4158\/EP14483.OR_bb0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.CIR.0000055188.83694.B3","article-title":"Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue","volume":"107","author":"Ouchi","year":"2003","journal-title":"Circulation"},{"key":"10.4158\/EP14483.OR_bb0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000141930","article-title":"Adiponectin is related to carotid artery plaque and a predictor of cardiovascular outcome in a cohort of non-diabetic peritoneal dialysis patients","volume":"26","author":"Yu","year":"2008","journal-title":"Blood Purif"},{"key":"10.4158\/EP14483.OR_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000085707","article-title":"Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease-a follow-up study","volume":"101","author":"Ignacy","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.4158\/EP14483.OR_bb0150","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.2169\/internalmedicine.51.8636","article-title":"Total and HMW adiponectin is independently associated with B-type natriuretic peptide and anemia in chronic hemodialysis patients","volume":"51","author":"Abe","year":"2012","journal-title":"Intern Med"},{"key":"10.4158\/EP14483.OR_bb0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ki.2011.105","article-title":"Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis","volume":"80","author":"Oh","year":"2011","journal-title":"Kidney Int"},{"key":"10.4158\/EP14483.OR_bb0160","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s11255-014-0723-0","article-title":"Cinacalcet may improve oxidative DNA damage in maintenance hemodialysis patients: an observational study","volume":"46","author":"Ari","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.4158\/EP14483.OR_bb0165","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"key":"10.4158\/EP14483.OR_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/ajpregu.00745.2006","article-title":"Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease--impact on plasma adiponectin concentration","volume":"293","author":"Barazzoni","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.4158\/EP14483.OR_bb0175","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000107509","article-title":"Association of plasma adiponectin levels with oxidative stress in hemodialysis patients","volume":"25","author":"Lim","year":"2007","journal-title":"Blood Purif"},{"key":"10.4158\/EP14483.OR_bb0180","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.metabol.2007.01.018","article-title":"Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease","volume":"56","author":"Lautam\u00e4ki","year":"2007","journal-title":"Metabolism"},{"key":"10.4158\/EP14483.OR_bb0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2169\/internalmedicine.47.0614","article-title":"Association of serum adiponectin levels with all-cause mortality in hemodialysis patients","volume":"47","author":"Ohashi","year":"2008","journal-title":"Intern Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20356901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20356901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/7032N8671R37KP17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:58:31Z","timestamp":1761515911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20356901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1530891X20356901"],"URL":"https:\/\/doi.org\/10.4158\/ep14483.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment With Cinacalcet Increases Plasma Adiponectin Concentration in Hemodialyzed Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14483.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}